EUVIMEDEUVIMED entdecken
Kohortenstudie

Association of metformin with osteoarthritis progression and total joint arthroplasty: evidence from the UK Biobank, a large population-based cohort study

Yunze Kang, Yiling Liu, Lingli Long, Weishen Chen, Zhiqi Zhang, Minghui Gu, Chao Wang, Chengxin Li, Shiyong Zhang, Baiqi Pan, Xiaoyu Wu, Ali Mobasheri und 3 weitere

Clinical Rheumatology · 2026-08 · 45 (8) · 5063-5073

DOI: 10.1007/s10067-026-08181-0 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Rheumatology, online erschienen am 29.06.2026. Verfasst von Yunze Kang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Joint Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, China. Hauptthemen laut MEDLINE: Metformin, Hypoglycemic Agents, Osteoarthritis, Osteoarthritis, Hip. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To assess the association between metformin and osteoarthritis (OA) development and total joint arthroplasty (TJA) in a large prospective cohort. METHODS: From the UK Biobank, 348,070 people between the ages of 40 and 69 who did not have OA or TJA at baseline were included between 2006 and 2010 and investigated until January 2021. We used multivariable-adjusted Cox regression to test for an association between metformin and OA diagnosis (n = 51,111) and OA-related TJA (n = 21,754) in the cohort. Models 1 and 2 were adjusted for age, sex, and diabetes. Model 2 was also adjusted for additional variables, including the Townsend Deprivation Index, ethnicity, household income, body mass index, glycated hemoglobin, smoking and alcohol status, physical activity, hypertension, and medications including antihypertensive drug use, statin use, insulin treatment, aspirin use and glucosamine/chondroitin supplementation. RESULTS: At baseline, 14,128 (4.06%) of the 348,070 participants reported metformin prescriptions. The hazard ratio (HR) for OA, including knee OA (HR, 0.74; 95% confidence intervals (CI), 0.69 to 0.80) and hip OA (HR, 0.74; 95% CI 0.67 to 0.82), was 0.74 (95% CI, 0.70 to 0.77) for metformin users versus nonusers, but not hand OA (HR, 0.91; 95% CI 0.68 to 1.21). Metformin also reduced the risk of TJA (HR, 0.72; 95% CI 0.67 to 0.78). For OA, the association seemed to be stronger among nonobese, nondiabetic, and nonhypertensive participants (all p < 0.05). CONCLUSIONS: Metformin seems to reduce the risk of OA and TJA and may protect against OA in the general population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminHypoglycemic AgentsOsteoarthritisOsteoarthritis, HipOsteoarthritis, KneeHumansFemaleMaleMiddle AgedUnited KingdomAgedAdultDisease ProgressionProspective StudiesUK BiobankProportional Hazards ModelsBiological Specimen Banks

Stichwörter der Autor:innen

MetforminOsteoarthritisPopulation-based cohort studyTotal joint arthroplastyUK Biobank

Substanzen

MetforminHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Joint Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, China.
  • Guangdong Provincial Key Laboratory of Orthopaedics and Traumatology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, Guangdong, China.
  • Department of Burn and Wound Repair Surgery, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, Guangdong, China.
  • Research Center of Translational Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, Guangdong, China.
  • Department of Joint Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, China. ali.mobasheri@oulu.fi.
  • Research Unit of Health Sciences and Technology, University of Oulu, Oulu, Finland. ali.mobasheri@oulu.fi.

Förderung

  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Kang, Y., Liu, Y., Long, L., Chen, W., Zhang, Z., Gu, M., Wang, C., Li, C., Zhang, S., Pan, B., Wu, X., Mobasheri, A., Zhang, Z., Sheng, P., & Zheng, L. (2026). Association of metformin with osteoarthritis progression and total joint arthroplasty: evidence from the UK Biobank, a large population-based cohort study. Clinical Rheumatology, 45(8), 5063-5073. https://doi.org/10.1007/s10067-026-08181-0

Vancouver

Kang Y, Liu Y, Long L, Chen W, Zhang Z, Gu M, et al. Association of metformin with osteoarthritis progression and total joint arthroplasty: evidence from the UK Biobank, a large population-based cohort study. Clinical Rheumatology. 2026;45(8):5063-5073. doi:10.1007/s10067-026-08181-0

BibTeX
@article{Kang2026,
  author = {Kang, Yunze and Liu, Yiling and Long, Lingli and Chen, Weishen and Zhang, Zhiqi and Gu, Minghui and Wang, Chao and Li, Chengxin and Zhang, Shiyong and Pan, Baiqi and Wu, Xiaoyu and Mobasheri, Ali and Zhang, Ziji and Sheng, Puyi and Zheng, Linli},
  title = {Association of metformin with osteoarthritis progression and total joint arthroplasty: evidence from the UK Biobank, a large population-based cohort study},
  journal = {Clinical Rheumatology},
  year = {2026},
  volume = {45},
  number = {8},
  pages = {5063--5073},
  doi = {10.1007/s10067-026-08181-0}
}
Kostenlos starten →